These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 1972296

  • 1. The role of mesalazine in Crohn's disease.
    Hanauer SB.
    Scand J Gastroenterol Suppl; 1990; 172():56-9. PubMed ID: 1972296
    [Abstract] [Full Text] [Related]

  • 2. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.
    Steinhart AH, Hemphill D, Greenberg GR.
    Am J Gastroenterol; 1994 Dec; 89(12):2116-24. PubMed ID: 7977225
    [Abstract] [Full Text] [Related]

  • 3. Maintenance of symptomatic remission in patients with Crohn's disease.
    Stark ME, Tremaine WJ.
    Mayo Clin Proc; 1993 Dec; 68(12):1183-90. PubMed ID: 7902474
    [Abstract] [Full Text] [Related]

  • 4. Aminosalicylates for induction of remission or response in Crohn's disease.
    Lim WC, Hanauer S.
    Cochrane Database Syst Rev; 2010 Dec 08; (12):CD008870. PubMed ID: 21154400
    [Abstract] [Full Text] [Related]

  • 5. Maintenance of remission in Crohn's disease: is 5'-aminosalicylic acid the answer?
    Tremaine WJ.
    Gastroenterology; 1992 Aug 08; 103(2):694-6. PubMed ID: 1353043
    [No Abstract] [Full Text] [Related]

  • 6. Is maintenance therapy effective in Crohn's disease?
    Greenberger NJ, Miner PB.
    Lancet; 1994 Oct 01; 344(8927):900-1. PubMed ID: 7934340
    [No Abstract] [Full Text] [Related]

  • 7. The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease.
    Bonapace CR, Mays DA.
    Ann Pharmacother; 1997 Oct 01; 31(7-8):907-13. PubMed ID: 9220055
    [Abstract] [Full Text] [Related]

  • 8. Is Asacol as effective as sulphasalazine in maintaining remission of Crohn's disease and ulcerative colitis?
    Nakshabendi IM, Duncan A, Russell RI.
    Postgrad Med J; 1992 Mar 01; 68(797):189-91. PubMed ID: 1350343
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mesalazine as maintenance treatment in Crohn's disease.
    Vos J, Lesterhuis W.
    Gastroenterology; 1994 Feb 01; 106(2):553-4. PubMed ID: 8299923
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis.
    Coward S, Kuenzig ME, Hazlewood G, Clement F, McBrien K, Holmes R, Panaccione R, Ghosh S, Seow CH, Rezaie A, Kaplan GG.
    Inflamm Bowel Dis; 2017 Mar 01; 23(3):461-472. PubMed ID: 28146003
    [Abstract] [Full Text] [Related]

  • 18. Sulfasalazine and new analogues in inflammatory bowel disease, with focus on Crohn's disease.
    van Hees PA.
    Acta Gastroenterol Belg; 1987 Mar 01; 50(5):555-9. PubMed ID: 2902723
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.